LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-27.01% | 9.96 Mrd. | |
-8.58% | 3.03 Mrd. | |
+31.86% | 3 Mrd. | |
-13.62% | 2.18 Mrd. | |
-16.32% | 1.76 Mrd. | |
+63.36% | 1.42 Mrd. | |
+27.00% | 794 Mio. | |
-2.18% | 756 Mio. | |
+3.18% | 305 Mio. |